Brominated fire retardants, used in many consumer products and known to cause hormonal irregularities, overstimulates an adrenal gland hormone in a way that may lead to the development of cardiovascular disease, new research in human cells finds.
New research suggests pretreating cells with a peptide hormone may improve the success rate of pancreatic islet cell transplants, a procedure that holds great promise for curing Type 1 diabetes.
Aromatase inhibitors, when used for up to three years in combination with growth hormone, may effectively and safely help very short adolescent boys grow taller, new research suggests.
In obese middle-aged men, losing weight while dieting normally depletes both fat and muscle. But adding testosterone treatment may help them lose only fat and retain their muscle, new research suggests.
Young children who take antibiotics may disrupt their gut’s microbial ecosystem and be more likely to develop prediabetes in adolescence, new research reports.
A combined vaccine therapy including live Salmonella is a safe and effective way to prevent diabetes in mice and may point to future human therapies, a new study finds.
A new article provides much-needed guidance for critical care nurses and other clinicians whose patients experience continuous or recurrent seizures.
It could be perceived that social status can be correlated with better life chances and educational achievements for children. But is it all about the social background and income of the parents, or should children’s own cognitive abilities be taken into account? Recent research considers 4 key areas of parental social background against children’s cognitive ability to decipher their impact on educational outcomes.
Delayed or deferred stent implantation in patients experiencing the deadliest form of heart attack– – ST-segment elevation myocardial infarction (STEMI) – failed to reduce death from any cause, hospitalization for heart failure, subsequent heart attacks or the need for a repeat procedure to restore blood flow to the heart.
Giving intravenous beta blockers before performing a coronary angioplasty in patients who had experienced the deadliest form of heart attack—ST-segment elevation myocardial infarction (STEMI)—was safe but did not reduce heart attack severity or improve blood flow from the heart’s main pumping chamber.
